Epstein Becker Green (EBG) successfully moved to dismiss a putative class action in which the plaintiffs claimed that certain dietary supplements sold by the firm’s client contained ingredients that were not safe for human consumption and that the products were adulterated under the Food, Drug, and Cosmetic Act (FDCA). EBG struck an important blow against the plaintiffs’ lawyers’ ongoing attempts to privately enforce the FDCA.
Results may vary depending on your particular facts and legal circumstances.
People
- Member of the Firm
- Member of the Firm
- Associate